Drugging homologous recombination: back to the future
Member Exclusive Journal Content
Natural antioxidants in hybrids for the treatment of neurodegenerative diseases: a successful strategy?
Perspective: the benefits of in silico modeling to identify possible small-molecule drugs and their off-target interactions
Research article: enhancing anticancer activity through the combination of bioreducing agents and triterpenes